Pharmaceutical Regulatory Affairs Journals Publications
The Pharmaceutical Regulatory Affairs:
Open Access is an academic journal – hosted by OMICS International – a pioneer in
open access publishing and is listed among the top 10
journals in pharmaceutical regulatory affairs. Each year research scientists have observed an increase in the number of congresses being held in this field. The Pharmaceutical Regulatory Affairs is an
Open Access provides a unique platform to researchers and scientist to review the advanced and latest research developments in the field of and pharmacy and pharmaceutical regulatory affairs, thus crossing the gap between researchers and young scientists.
High Impact List of Articles
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors: recent outcomes from clinical trials and the implications for oncology treatment approaches
Alexandra MR Marsh, Ruth Narramore, Keith Chapple, Alan J Lobo, Jonathan RL Wild, Bernard M Corfe
Review: Clinical Trail Outcomes: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Potential benefits of ketamine seen in antidepressent clinical trial
News and Views: Clinical Investigation
-
Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network
Peter J Connelly, Emma Law, John M Starr
Research Update: Clinical Investigation
-
Developing clinical research infrastructure in Scotland: the Scottish Dementia Clinical Research Network
Peter J Connelly, Emma Law, John M Starr
Research Update: Clinical Investigation
-
New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH
Irene M Lang
Review: Clinical Trail Outcomes: Clinical Investigation
-
New developments in the treatment of chronic thromboembolic pulmonary hypertension*** Pharmacological treatment of CTEPH
Irene M Lang
Review: Clinical Trail Outcomes: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
-
Vitamin D as an adjuvant therapy for tuberculosis: pharmacogenomic implications
Dilip Nazareth, Peter Davies
Editorial: Clinical Investigation
Relevant Topics in Clinical